Helen M Palethorpe
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 02, 2021
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models.Maryam Nakhjavani, Eric Smith, Helen M Palethorpe
|Jun 02, 2021
In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca2+ Flux and Loss of Plasma Membrane Integrity.Yoko Tomita, Eric Smith, Helen M Palethorpe
|Jun 02, 2021
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments.Maryam Nakhjavani, Eric Smith, Kenny Yeo
|Oct 11, 2019
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe
|Oct 03, 2019
Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines.Helen M Palethorpe, Eric Smith, Yoko Tomita
|Apr 25, 2019
Bumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In Vitro.Yoko Tomita, Helen M Palethorpe, Eric Smith
Pageof 2
Frequent Collaborators
7 joint publications
Jennifer E Hardingham
6 joint publications
Eric Smith
6 joint publications
Maryam Nakhjavani
4 joint publications
Yoko Tomita
3 joint publications
Andrea J Yool
2 joint publications
Timothy J Price
2 joint publications
Kenny Yeo
1 joint publications
Joanne P Young
1 joint publications
Amanda R Townsend
